Cara Therapeutics | CARA - Ativo Circulante





Ativo Circulante Alterar Data
Acadia Pharmaceuticals USD 1.06B 14.31M 2025-12
Alterity Therapeutics Limited AUD 37.91M 15.92M 2025-12
Assertio Holdings USD 263.57M 53.36M 2025-09
Cara Therapeutics USD 38.44M 4.69M 2025-09
Cassava Sciences USD 97.71M 11.2M 2025-12
Chugai Pharma JPY 1.54T 201.32B 2026-03
Cipla INR 249.18B 16.3B 2025-09
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 148.02M 59.1M 2025-12
CSL USD 11.85B 1000K 2025-12
Grifols EUR 5.96B 316.31M 2025-12
Halozyme Therapeutics USD 825.21M 503.54M 2025-12
J&J USD 59.17B 3.55B 2026-03
Neurocrine Biosciences USD 2.44B 86.6M 2026-03
Pacira USD 514.96M 33.01M 2026-03
Pfizer USD 42.82B 76M 2026-03
RedHill Biopharma USD 12.56M 644K 2025-06
Supernus Pharmaceuticals USD 731.58M 87.4M 2026-03
Vanda Pharmaceuticals USD 347.26M 20.23M 2025-12